A Randomized Multicenter Comparison of Basiliximab and Muromonab (OKT3) in Heart Transplantation: SIMCOR Study-Reference-Cited by-同舟云学术

A Randomized Multicenter Comparison of Basiliximab and Muromonab (OKT3) in Heart Transplantation: SIMCOR Study

Published:2006-06 Issue:11 Volume:81 Page:1542-1548
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Segovia Javier,Rodr??guez-Lambert Jos?? L.,Crespo-Leiro Maria G.,Almenar Luis,Roig Eul??lia,G??mez-S??nchez Miguel A.,Lage Ernesto,Manito Nicolas,Alonso-Pulp??n Luis

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference31 articles.

1. The registry of the international society for heart and lung transplantation: twentieth official adult heart transplant report—2003

2. Drug Therapy in the Heart Transplant Recipient

3. Prophylactic therapy for rejection after cardiac transplantation

4. Systemic Reaction to the Anti–T-Cell Monoclonal Antibody OKT3 in Relation to Serum Levels of Tumor Necrosis Factor and Interferon-α

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioreceptors for Affinity Binding in Theranostic Development;Biosensors Nanotechnology;2023-09-13

2. The impact of induction therapy on mortality and treated rejection in cardiac transplantation: A retrospective study;The Journal of Heart and Lung Transplantation;2022-04

3. Novel Immunosuppression in Solid Organ Transplantation;Pharmacology of Immunosuppression;2022

4. RETRACTED ARTICLE: Two dimensional speckle tracking echocardiography detects cardiac allograft stage III vasculopathy in recipients of heart transplants with preserved systolic function;Acta Cardiologica;2020-07-31

5. Early experience with pediatric cardiac transplantation in a limited resource setting;Annals of Pediatric Cardiology;2020